Multisystem Inflammatory Syndrome Due to COVID-19 Infection in Vaccinated Versus Unvaccinated Adolescents: A Case Report.
| Autor: | Zapata MR; Family Medicine, University of the Incarnate Word School of Osteopathic Medicine, San Antonio, USA., Pandit T; Pediatrics, Nemours Children's Health, Glen Mills, USA., Goyal L; Hospital Medicine, CHRISTUS Spohn Hospital Corpus Christi - Shoreline, Corpus Christi, USA., Ajmera K; Hospital Medicine, Sentara Northern Virginia Medical Center, Woodbridge, USA., Chourasia P; Hospital Medicine, Mary Washington Hospital, Fredericksburg, USA., Pandit R; Medicine, Independent Researcher, Philadelphia, USA.; Hospital Medicine, University of Pennsylvania, Chester County Hospital, Philadelphia, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Sep 19; Vol. 15 (9), pp. e45564. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.45564 |
| Abstrakt: | Symptoms of COVID-19 infection are usually mild in the healthy pediatric population. In some pediatric patients, COVID-19 infection can lead to multisystem inflammatory syndrome in children (MIS-C). We report two cases. Case 1 is a rare case of MIS-C symptoms, presenting with myalgia, chest pain, and fever three days after the second dose of the Pfizer-BioNTech COVID-19 vaccine, which is compared with Case 2, which is a case of MIS-C in an unvaccinated patient with COVID-19 infection who was noted to have acute kidney injury and fluid refractory hypotension. Although MIS-C was reported as a vaccine side effect, we conclude that COVID-19 infection led to the development of MIS-C in our case, not the COVID-19 vaccine. MIS-C symptoms were also noted to be less severe after the COVID-19 vaccine than in the unvaccinated patients. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Zapata et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|